Adagrasib/Cetuximab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of adagrasib and cetuximab that may be used in the treatment of KRAS G12C mutation-positive colorectal cancer, appendiceal cancer, and small bowel adenocarcinoma.

**Synonyms:** - Adagrasib and Cetuximab - Adagrasib-Cetuximab - Adagrasib/Cetuximab - Cetuximab-Adagrasib - Cetuximab/Adagrasib - Krazati/Erbitux Regimen